By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Adocia 

115 avenue Lacassagne

Lyon    69003  France
Phone: +33-(0)4-72-610-610 Fax: +33-(0)4-72-363-967


SEARCH JOBS


Industry
Biotechnology

Segment
Biotechnology





Company News
Adocia Announces Approval To Start A Phase IIa Clinical Study Of Hinsbet®, Its Fast-Acting Human Insulin, In Type 1 Diabetes 7/9/2014 11:02:40 AM
Adocia Reports Positive Results From Phase 2a Clinical Study Of Ultra-Fast Acting Biochaperone® Lispro 4/9/2014 2:16:54 PM
Adocia Announces Financial Results For 2013 3/26/2014 11:22:43 AM
Adocia Confirms Positive Clinical Results For Its Biochaperone® Combo, A Combination Of Long-Acting Insulin Glargine And Fast-Acting Insulin Lispro 3/20/2014 11:41:00 AM
Adocia Announces Preliminary Positive Clinical Results For Its Combination Of Long-Acting Insulin Glargine And Fast-Acting Insulin Analog Lispro, Biochaperone® Combo 2/27/2014 11:11:28 AM
Adocia: Annual Revenue Of EUR 5.6 Million In 2013 2/18/2014 1:20:22 PM
Adocia Strengthens Its Diabetic Foot Ulcer Patent Portfolio 1/13/2014 10:04:45 AM
Adocia Launches Phase 2a Clinical Trial For Its Ultra-Fast Acting Formulation Of Analog Insulin 1/6/2014 10:09:30 AM
Adocia Announces The Initiation Of A Clinical Trial On Its Combination Of The Long-Acting Insulin Glargine And A Fast-Acting Insulin Analog 11/13/2013 10:25:19 AM
Adocia Announces Revenues of EUR 4.7 Million for the Third Quarter of 2013 With No Cash Impact 10/23/2013 11:35:36 AM
123
//-->